
CNBC's "Fast Money" Trouble Under The Rally’s Surface? Plus Improvements in Office Demand 8/8/24
Aug 8, 2024
The podcast dives into the recent S&P rally driven by positive jobless claims data, while questioning the sustainability of this surge. There's a spotlight on Eli Lilly's impressive growth in the pharma sector, particularly its weight loss drugs. The uptick in Manhattan office demand signals a recovery in corporate real estate. Additionally, they unpack Paramount's mixed earnings, the challenges facing streaming giants, and the contrasting performances in travel and real estate. Overall, it's a lively discussion on market trends and underlying economic concerns.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 2min
Market Fluctuations and Investor Sentiments
02:24 • 9min
Eli Lilly's Strategic Growth in Pharma
11:21 • 10min
Navigating Healthcare Costs and Corporate Developments
21:32 • 1min
Paramount's Financial Landscape and Streaming Sector Challenges
23:01 • 5min
Financial Insights and Market Reactions
27:31 • 4min
Market Insights and Trends
31:16 • 13min
Market Insights and Stock Performance Analysis
44:09 • 2min
